NCT00779116View on ClinicalTrials.gov

Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)

PHASE4CompletedINTERVENTIONAL

Enrollment

217

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions

Allergies

Interventions

DRUG

Desloratadine

SCH 34117: desloratadine RediTabs, 1 tablet (2.5 mg), oral administration, single dose, single day

DRUG

Zyrtec® (cetirizine)

Zyrtec® (cetirizine) Chewable Tablets, 1 tablet (5 mg), oral administration, single dose, single day

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00779116 - Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED) | Biotech Hunter | Biotech Hunter